(Circulation. 2008;118:904-906.)
© 2008 American Heart Association, Inc.
Editorial |
From the Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago.
Correspondence to Philip B. Gorelick, MD, MPH, John S. Garvin Professor and Head, Director, Center for Stroke Research, Department of Neurology and Rehabilitation, University of Illinois College of Medicine at Chicago, 912 S Wood St, Room 855N, Chicago, IL 60612. E-mail pgorelic{at}uic.edu
Key Words: Editorials lifestyle stroke prevention risk
| Introduction |
|---|
|
|
|---|
15 years of age.1 Stroke was responsible for an estimated 5.7 millions deaths in 2005, with
87% of the deaths occurring in low- and middle-income countries. It is the fourth leading cause of disease burden as determined by disability-adjusted life-years. In the United States, stroke caused an estimated 1 in 16 deaths in 2004;
780 000 new or recurrent strokes occurred; and 15% to 30% of stroke survivors were permanently disabled.2 In the United States in 2008, the direct and indirect cost of stroke is estimated to be $65.5 billion. Globally, stroke death is anticipated to rise to 6.5 million in 2015 and 7.8 million in 2030.1 Although stroke poses a major public health challenge, it is preventable.3 Observational epidemiological studies and clinical trials have laid the groundwork for well-developed evidence-based stroke prevention guidelines.
Article p 947
The INTERHEART study helped to clarify the role of traditional cardiovascular risk factors in coronary heart disease among 15 152 cases of acute myocardial infarction and 14 820 controls in 52 countries on every inhabited continent.4 This important observational epidemiological study showed that for men and women, old and young, and in all areas of the world, 9 potentially modifiable factors accounted for >90% of the proportion of the risk of initial acute myocardial infarction. The factors were abnormal lipids; smoking; hypertension; diabetes; abdominal obesity; psychosocial factors; consumption of fruits, vegetables, and alcohol; and regular physical activity. Because coronary heart disease and stroke share common risk factors,5 a combination of healthy lifestyle factors also might influence stroke risk. There has been a relatively paucity of information, however, in this area of study.
| Primary Prevention of Stroke by Healthy Lifestyle: Study Design and Results |
|---|
|
|
|---|
|
Overall, there were 1559 cases of stroke in women, of which 853 were ischemic, 278 were hemorrhagic, and 428 were of unknown type, in NHS and 994 cases of stroke in men, of which 600 were ischemic, 161 were hemorrhagic, and 233 were of unknown type, in HPFS.6 Twenty-five percent and 23% of total strokes requiring hospitalization but for which medical records were not available were designated as probable in NHS and HPFS, respectively. For both women and men who had all 5 low-risk factors, there was a dramatic reduction in total and ischemic stroke risk (Table 2). The associations between low-risk lifestyle factors and hemorrhagic stroke followed a pattern similar to that of ischemic stroke but were not as strong because the number of incident hemorrhagic strokes was low and the population-attributable risk percent estimates were unstable and had relatively wide confidence limits. Finally, for both women and men, total and ischemic strokes were significantly associated with adherence to a low-risk lifestyle (Table 2). The authors estimated that more than half of the ischemic strokes in either group could have been prevented if all had been in the low-risk healthy lifestyle group.
|
| Commentary and Interpretation of Study Results |
|---|
|
|
|---|
Lifestyle management may be an effective way to reduce or delay stroke and cardiovascular disease risk. A recently published study, for example, the Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme (EuroAction), has shown that multidisciplinary programs are a means to achieve potential for cardiovascular prevention in coronary heart disease and other high-risk patients. This may be accomplished through lifestyle management, management of blood pressure, maintenance of lipids and blood glucose at target levels, and prescription of cardioprotective drugs.10 In addition, group-based lifestyle interventions (eg, diet and exercise) over years may prevent or delay cardiovascular risks such as diabetes,11 and a culturally sensitive, enhanced care package may lead to some improvement in blood pressure and total cholesterol in type 2 diabetics.12 Whereas lifestyle management may be important to preventive efforts, as we age and risk factors such as high blood pressure and lipids become more pronounced, the addition of pharmacological treatment may be necessary.13
A key message of the study by Chiuve et al6 is that those with all 5 low-risk lifestyle factors had a substantial reduction (
80% for women and 70% to 80% for men) of total or ischemic stroke compared with those who had none of the factors.6 In addition, as the number of low-risk factors increased from 3 (not smoking, top 40% of Alternate Healthy Eating Index diet score, exercise
30 min/d) to 4 (addition of body mass index <25 kg/m2) to 5 (addition of alcohol 5 to 15 g/d), there was a stepwise increase in population-attributable risk percent from 34% to 41% to 54% in women and from 16% to 42% to 52% in men, respectively, for ischemic stroke. Similarly, in women and men, there was a stepwise increase in population-attributable risk percent as the number of low-risk factors increased for total stroke. Furthermore, when population-attributable risk percent was calculated using alternate definitions of low risk (eg, most recent rather than baseline body mass index, 0.1 g/d alcohol as the lower limit of low risk, Dietary Approaches to Stop Hypertension dietary scores, or 6-nutrient diet scores), results were consistent or comparable. Overall, the findings of benefit for low-risk lifestyle in this study6 were similar to those of other studies.14,15
Healthy aging may be predicated at least in part on a low-risk cardiovascular disease profile.16 In the Honolulu Asia Aging Study (HAAS), exceptional survival, defined as survival to a specified age without incidence of 6 major chronic diseases and without physical and cognitive impairment, was associated with avoidance of overweight, hyperglycemia, hypertension, smoking, excessive alcohol consumption, and other factors in 85-year-old subjects.17 How common, however, is a low-risk profile in the community? In the present study, among the NHS subjects (women), 2% were at low risk for all 5 factors, and 4% were at low risk for none of the factors.6 In the HPFS (men), 2% were at low risk for all 5 factors, and 2% were at low risk for none of the factors.6 In a study involving 5 cohorts with low risk defined as serum cholesterol <200 mg/dL, blood pressure
120/80 mm Hg, and no current cigarette smoking, only
5% to 10% in the cohorts fell into the low-risk category.15 In HAAS, 2451 (42%) survived to 85 years of age, and 11% met the criteria for exceptional survival.17 Therefore, the existence of true low-risk persons in the community based on lifestyle and other cardiovascular risk factors may be uncommon. Because this seems to be the case and because the lifestyle and other modifiable antecedents of coronary heart disease and stroke are prevalent in the community,3–5,18 the complementary mass and high-risk approaches to prevention remain a reasonable course of action.7 As we better understand the role of age as a "modifiable" risk factor13 and the influence of interventions on early life, potentially harmful socioeconomic-related factors,19 we may be better positioned to ward off the development of key lifestyle and other cardiovascular risk factors.
The Chronic Disease Action Group has provided a call to action to encourage, support, and monitor activity on the implementation of evidence-based efforts to achieve global, regional, and national programs to prevent and control chronic diseases.20 Central to a successful global strategy is emphasis on a few key modifiable risks for chronic disease. These include unhealthy diet, physical inactivity, and tobacco use. Evidence-based interventions for populations and individuals have emerged to control such factors and may be cost worthy. Multisectoral policies are advocated with long-term, sustainable action plans to empower individuals, families, and communities to change their behavior to a health-conscious one.20 Optimism exists for this strategy, especially as it applies to low- and middle-income countries, although additional integrated stepwise surveillance and health outcomes research are needed to solidify the approach.
This carefully done, insightful, and highly relevant analysis by Chiuve et al has potential limitations, as pointed out by the authors, in areas such as measurement error in self-reported variables; nondifferential misclassification, which could underestimate true relative risk; residual confounding; and underestimation of the burden of unhealthy behavior.6 However, the data remain consistent with other studies,14,15 and these potential study limitations should not deter us from concluding, as the authors have, that a low-risk lifestyle profile is associated with a substantial reduction in stroke risk. Furthermore, one wonders what may have led to adherence to an overall low-risk lifestyle in the Chiuve et al study subjects and if this information can be applied to the community at large.
Because the combined health benefits may be considerable for not smoking, consuming alcohol in moderation (if one chooses to), maintaining a proper diet, exercising regularly, and keeping weight down, a more challenging matter is to shift the risk profile of the community at large in this direction in a sustainable manner. It seems that only a relatively small percentage of us are able to maintain such a healthy lifestyle profile. There are many temptations for unhealthy lifestyle choices before us and counterforces that detract from health-promotion efforts. Therefore, we have a significant challenge in our midst before we can claim victory of achieving a remarkable record for healthy lifestyle factors in individuals and the population.
| Acknowledgments |
|---|
Dr Gorelick serves on and receives honoraria for participation on a safety committee for Norvartis (Aliskiren); on steering committees for Bayer for the ARRIVE trial; for Boehringer Ingelheim for the PRoFESS trial; for Brainsgate (sphenopalatine ganglion stimulator for acute ischemic stroke); for Pharm-D (neuroprotectant in acute ischemic stroke); for adjudication committees for Myriad, TAP, and Pfizer; for a data monitoring board for Statistical Collaborative; and as a consultant for Daiichyi Sankyo (olmesartan). He has lectured for and received honoraria from diaDexus and Boehringer Ingelheim.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Rosamond W, Flegal K, Furie K, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y, for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. AHA heart disease and stroke statistics: 2008 update. Circulation. 2008; 117: e25–e146.
3. Gorelick PB, Sacco RL, Smith DB, Alberts M, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC. Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus from the National Stroke Association. JAMA. 1999; 281: 1111–1120.
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L, for the INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004; 364: 937–952.[CrossRef][Medline] [Order article via Infotrieve]
5. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, Culebras A, DeGraba TJ, Gorelick PB, Guyton JR, Hart RG, Howard G, Kelly-Hayes M, Nixon JV, Sacco RL. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Stroke. 2006; 37: 1583–1633.
6. Chiuve SE, Rexrode KM, Spiegelman D, Logroscino G, Manson JE, Rimm EB. Primary prevention of stroke by healthy lifestyle. Circulation. 2008; 118: 947–954.
7. Rose G. The Strategy of Preventive Medicine. New York, NY: Oxford University Press; 1994: 1–138.
8. Woolf SH. The power of prevention and what it requires. JAMA. 2008; 299: 2437–2439.
9. Mackenbach JP, Stirbu I, Roskam A-JR, Schaap MM, Menvielle G, Liensalu M, Kunst A, for the European Union Working Group on Socioeconomic Inequalities in Health. Socioeconomic inequalities in health in 22 European countries. N Engl J Med. 2008; 358: 2468–2481.
10. Wood DA, Kotseva K, Connolly S, Jennings C, Mead Jones A, Holden A, De Bacquer D, Collier T, De Backer G, Faergeman O, for the EUROACTION Study Group. Nurse-Coordinated Multidisciplinary, Family-Based Cardiovascular Disease Prevention Programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomized controlled trial. Lancet. 2008; 371: 1999–2012.[CrossRef][Medline] [Order article via Infotrieve]
11. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, Li H, Li H, Jiang Y, An Y, Shuai Y, Zhang B, Zhang J, Thompson TJ, Gerzoff RB, Roglic G, Hu Y, Bennett PH. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Province Prevention Study: a 20-year follow-up study. Lancet. 2008; 371: 1783–1789.[CrossRef][Medline] [Order article via Infotrieve]
12. Bellary S, O'Hare JP, Raymond NT, Gumber A, Mughai S, Szczepura A, Kumare S, Bennett AH, for the UKADS Study Group. Enhanced diabetes care to patients of south Asian ethnic origin (the United Kingdom Asian Diabetes Study): a cluster randomized controlled trial. Lancet. 2008; 371: 1769–1776.[CrossRef][Medline] [Order article via Infotrieve]
13. Sniderman AD, Furberg CD. Age as a modifiable risk factor for cardiovascular disease. Lancet. 2008; 371: 1547–1549.[CrossRef][Medline] [Order article via Infotrieve]
14. Kurth T, Moore SC, Gaziano JM, Kase CS, Stampfer MJ, Berger K, Buring JE. Healthy lifestyle and the risk of stroke in women. Arch Intern Med. 2006; 166: 1403–1409.
15. Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, Dyer AR, Liu K, Greenland P. Low risk-factor profile and long-term expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999; 282: 2012–2019.
16. Gorelick PB. William M. Feinberg lecture: cognitive vitality and the role of stroke and cardiovascular disease risk factors. Stroke. 2005; 36: 875–879.
17. Willcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, Donlon TA, Willcox DC, Curb DJ. Midlife risk factors and healthy survival in men. JAMA. 2006; 296: 2343–2350.
18. Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003; 290: 891–897.
19. William RB. Lower socioeconomic status and increased mortality: early childhood roots and potential successful interventions. JAMA. 1998; 279: 1745–1746.
20. Beaglehole R, Ebrahim S, Reddy S, Voute J, Leeder S, for the Chronic Disease Action Group. Prevention of chronic diseases: a call to action. Lancet. 2007; 370: 2152–2157.[Medline] [Order article via Infotrieve]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |